Izotropic Corporation (IZO.CN)
- Previous Close
0.2300 - Open
0.2400 - Bid 0.2400 x --
- Ask 0.2600 x --
- Day's Range
0.2400 - 0.2400 - 52 Week Range
0.0350 - 0.4700 - Volume
4,000 - Avg. Volume
40,448 - Market Cap (intraday)
13.631M - Beta (5Y Monthly) 1.94
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date Apr 1, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.
izocorp.comRecent News: IZO.CN
View MorePerformance Overview: IZO.CN
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IZO.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IZO.CN
View MoreValuation Measures
Market Cap
13.06M
Enterprise Value
14.87M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-200.68%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.09M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
220.78k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
236.04k